USP evaluates raw materials used in the chemical synthesis of peptides.
Michael Verlander
Advertisement
Michael Verlander is technical advisor at PolyPeptide Group.
Articles by Michael Verlander
USP evaluates quality attributes for synthetic peptides.
Advertisement
Latest Updated Articles
Control Strategies for Synthetic Therapeutic Peptide APIs Part II: Raw Material ConsiderationsPublished: April 1st 2014 | Updated:
Control Strategies for Synthetic Therapeutic Peptide APIs— Part I: Analytical ConsiderationPublished: March 1st 2014 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
5
